First use of ibrutinib for the treatment of post-transplant central nervous system graft-versus-host disease

Br J Haematol. 2023 Sep;202(5):1061-1064. doi: 10.1111/bjh.18959. Epub 2023 Jun 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adenine
  • Graft vs Host Disease* / drug therapy
  • Graft vs Host Disease* / etiology
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Piperidines

Substances

  • ibrutinib
  • Piperidines
  • Adenine